WebKey words: Chrysanthemum, organogenesis, 6-benzylamininopurine. ... Chrysanthemum nipponicum), a diploid-related species to cultivated hexaploid chrysanthemums. Effects of 6-benzylaminopurine (BA) and indolacetic acid (IAA), each at three levels of concentration, were tested on three progenies derived from self-fertilisation of a cultivated ... WebApr 27, 2024 · Propagation from Nonmeristematic Tissues-Organogenesis, O.J. Schwarz and R.M. Beaty Direct Shoot Organogenesis from Leaf Explants of Chrysanthemum, R.N. Trigiano and R.A. May Shoot Organogenesis from Cotyledon Explants of Watermelon, M.E. Compton and D.J. Gray Direct and Indirect Shoot Organogenesis from Leaves of …
Ornamental Chrysanthemums: Improvement by …
WebEksplan kotiledon, hipokotil, dan akar tanaman A3: IAA 0.3 mg L-1), dan faktor E (jenis eksplan) terdiri dari tomat yang diinduksi pada media yang mengandung BAP tiga taraf (E1: kotiledon, E2: hipokotil, E3: akar), dan didapat dan IAA, mengalami organogenesis tidak langsung atau 48 kombinasi perlakuan dengan 3 kali ulangan (1 ulangan melewati ... WebReproducible and efficient regeneration systems — via organogenesis and somatic embryogenesis— from three chrysanthemum ( D. grandiflora) varieties: Escapade, White Albatross, and Yellow Albatross were … on the go vegan snacks
Callus Induction and Plant Regeneration of Chrysanthemum ... - iau
WebDec 1, 2024 · Direct somatic embryogenesis from ray floret explants of five chrysanthemum cultivars has been obtained within 12 – 15 d on Murashige and Skoog medium supplemented with 2,4-dichlorophenoxyacetic acid… Expand 37 PDF View 2 excerpts, references background Organogenesis from chrysanthemum Dendranthema … WebThe principle objective of this study was to obtain defined organogenic programs (callus, adventitious shoots or roots, somatic embryos (SEs)) through the use of thin cell layer technology, in combination with plant … WebJun 22, 2014 · GCF is the proportional number of target organs that can be regenerated from a source organ when comparing two explants that differ in size and/or shape, that is, comparison of RCs on a 'per-organ-base'. Consequently, GF … on the government side